As of the latest Form 4 filed Jun 24, 2026.
What 10X Genomics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 29 most recent filings for TXG.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-24 | 2026-06-22 | Saxonov Serge Chief Executive Officer | SSale | −1.66K | $36.16 | $60.1K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Saxonov Serge, Chief Executive Officer | SSale | −9.82K | $35.32 | $347K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Saxonov Serge, Chief Executive Officer | SSale | −9.99K | $34.28 | $343K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Saxonov Serge, Chief Executive Officer | SSale | −8.53K | $33.29 | $284K | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | SULIMAN SHEHNAAZ Director | SSale | −364.00 | $33.27 | $12.1K | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | SULIMAN SHEHNAAZ, Director | SSale | −5.36K | $32.59 | $175K | Yes (planned) | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Teichmann Sarah A. Director | AAward | +8.83K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | SULIMAN SHEHNAAZ Director | AAward | +8.83K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | STUELPNAGEL JOHN R Director | AAward | +8.83K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Popovits Kimberly J Director | AAward | +8.83K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | MATEO ALAN Director | AAward | +8.83K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Kosaraju Sridhar Director | AAward | +8.83K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | Saxonov Serge Chief Executive Officer | SSale | −10.7K | $24.71 | $265K | Yes (planned) | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Saxonov Serge, Chief Executive Officer | SSale | −18.2K | $24.44 | $444K | Yes (planned) | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Hindson Benjamin J. See Remarks | SSale | −11.6K | $24.44 | $283K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Taich Adam Chief Financial Officer | SSale | −15.1K | $24.44 | $369K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-14 | Saxonov Serge Chief Executive Officer | SSale | −5.00K | $24.56 | $123K | Yes (planned) | Form 4 ↗ |
| 2026-03-25 | 2026-03-24 | Saxonov Serge Chief Executive Officer | SSale | −5.00K | $19.52 | $97.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-25 | 2026-03-23 | Saxonov Serge, Chief Executive Officer | SSale | −10.0K | $19.13 | $191K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Saxonov Serge Chief Executive Officer | GGift | −2.75K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Saxonov Serge, Chief Executive Officer | SSale | −1.86K | $23.18 | $43.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Saxonov Serge, Chief Executive Officer | SSale | −14.3K | $22.67 | $324K | Yes (planned) | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Saxonov Serge Chief Executive Officer | AAward | +158K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Hindson Benjamin J. See Remarks | AAward | +88.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Taich Adam Chief Financial Officer | AAward | +107K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Teichmann Sarah A. Director | SSale | −7.58K | $19.41 | $147K | Yes (planned) | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Saxonov Serge Chief Executive Officer | SSale | −9.63K | $18.58 | $179K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Taich Adam Chief Financial Officer | SSale | −8.97K | $18.58 | $167K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Hindson Benjamin J. See Remarks | SSale | −7.83K | $18.58 | $145K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also TXG’s full analysis or the market-wide insider trading feed. The tabs above jump to TXG’s other SEC data.
Source: SEC Form 4 filings for TXG, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.